Pharmaessentia Says To Buy 100% Forus Therapeutics For C$50 Mln
April 9 (Reuters) - PharmaEssentia Corp 6446.TW:
SAYS TO BUY 100% STAKE IN FORUS THERAPEUTICS INC FOR C$50 MILLION ($36.10 million)
Further company coverage: 6446.TW
($1 = 1.3852 Canadian dollars)
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Intel Q1 Earnings Preview: Triple Test of CPU, 18A Yields and Foundry Orders

Allbirds Ditches Sneakers and Pivots to AI Computing - Is BIRD Stock Still Worth Buying After a 600% Surge?

Bitcoin Breaks $78,000 Amid U.S.-Iran Conflict, Can It Return to $100,000 in 2026?

Asia-Pacific Stocks Rise Across the Board Monday as Easing Middle East Tensions Boost Market Sentiment

Nvidia Launches Ising Model Driving Quantum Sector Surge, QUBT vs IONQ, Which Is More Worth Investing In?

Tradingkey








